Viatris Inc. (VTRS) financial statements (2023 and earlier)

Company profile

Business Address 1000 MYLAN BOULEVARD
CANONSBURG, PA 15317
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments739  
Cash and cash equivalents701  
Short-term investments38  
Restricted cash and investments5  
Receivables3,774  
Inventory, net of allowances, customer advances and progress billings3,978  
Inventory3,978  
Prepaid expense257  
Other current assets1,467  
Other undisclosed current assets683  
Total current assets:10,903  
Noncurrent Assets
Property, plant and equipment3,189  
Intangible assets, net (including goodwill)38,248  
Goodwill12,114  
Intangible assets, net (excluding goodwill)26,134  
Deferred income tax assets1,333  
Other noncurrent assets1,171  
Total noncurrent assets:43,940  
TOTAL ASSETS:54,843  
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,894  
Accounts payable1,657  
Taxes payable237  
Other liabilities4,620  
Other undisclosed current liabilities3,371  
Total current liabilities:9,884  
Noncurrent Liabilities
Long-term debt and lease obligation19,918  
Long-term debt, excluding current maturities19,717  
Operating lease, liability201  
Liabilities, other than long-term debt, including:233  
Deferred income tax liabilities2,815  
Liability for uncertainty in income taxes426  
Liability, pension and other postretirement and postemployment benefits876  
Restructuring reserve64  
Other liabilities1,934  
Other undisclosed liabilities, other than long-term debt(5,883)  
Other undisclosed noncurrent liabilities4,315  
Total noncurrent liabilities:24,466  
Total liabilities:34,350  
Stockholders' equity
Stockholders' equity attributable to parent20,493  
Common stock12 0
Additional paid in capital18,536  
Accumulated other comprehensive loss(1,744)  
Retained earnings3,689  
Receivable from shareholders or affiliates for issuance of capital stock  (0)
Total stockholders' equity:20,493  
TOTAL LIABILITIES AND EQUITY:54,843  

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
Revenues17,886  
Cost of revenue
(Cost of Goods and Services Sold)
(12,311)  
Gross profit:5,576  
Operating expenses(5,610)  
Operating loss:(34)  
Nonoperating income
(Other Nonoperating income)
6  
Interest and debt expense(636)  
Loss from continuing operations before income taxes:(664)  
Income tax expense(605)  
Net loss available to common stockholders, diluted:(1,269)  

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
Net loss:(1,269)  
Other comprehensive loss(886)  
Comprehensive loss, net of tax, attributable to parent:(2,155)  

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: